Prostate Cancer Breakthroughs: PROTACs, PSA Testing & Your Path Forward
Update: 2025-07-14
Description
Explore PROTACs, the new frontier in prostate cancer treatment that destroys cancer-feeding proteins, with one drug currently in Phase 3 clinical trials. Learn why annual PSA tests are crucial for early detection in men aged 40-70 and understand NCCN guidelines for screening older men, considering factors like life expectancy. Gain insights into personalized treatment options and the importance of informed decisions for managing prostate cancer.
Comments
In Channel